Iresha Spizzo
Clayton, VIC 3800, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands.
Journal: European journal of medicinal chemistry
Published: November 11, 2023
Novel AT2R agonist, β-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 07, 2023
The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 21, 2022
The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice.
Journal: International journal of molecular sciences
Published: October 24, 2022
In Aged Females, the Enhanced Pressor Response to Angiotensin II Is Attenuated By Estrogen Replacement via an Angiotensin Type 2 Receptor-Mediated Mechanism.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: May 10, 2021
N-(Methyloxycarbonyl)thiophene sulfonamides as high affinity AT2 receptor ligands.
Journal: Bioorganic & medicinal chemistry
Published: September 16, 2020
Simultaneous targeting of oxidative stress and fibrosis reverses cardiomyopathy-induced ventricular remodelling and dysfunction.
Journal: British journal of pharmacology
Published: June 24, 2020
Serelaxin and the AT2 Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil.
Journal: ACS pharmacology & translational science
Published: November 01, 2019
Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.
Journal: Diabetes & vascular disease research
Published: September 27, 2015
β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats.
Journal: Clinical science (London, England : 1979)
Published: January 26, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026